Here is how Barinthus Biotherapeutics PLC Sponsored ADR (BRNS) and Agilent Technologies (A) have performed compared to their sector so far this year.
Detailed price information for Barinthus Biotherapeutics Plc ADR (BRNS-Q) from The Globe and Mail including charting and trades.
Scheme Exchange Ratio determined at 0.111 pursuant to the terms of the merger agreementScheme of arrangement expected to become effective on September 3,...
This is the newest page. Registered accounts read further back.